LifeStance Health Group (LFST) to Release Earnings on Thursday

LifeStance Health Group (NASDAQ:LFST) is set to post its quarterly earnings results before the market opens on Thursday, May 9th. Analysts expect LifeStance Health Group to post earnings of ($0.09) per share for the quarter. LifeStance Health Group has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Persons that wish to listen to the company’s earnings conference call can do so using this link.

LifeStance Health Group (NASDAQ:LFST) last released its earnings results on Wednesday, February 28th. The company reported ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.03). The firm had revenue of $280.60 million for the quarter, compared to the consensus estimate of $263.14 million. LifeStance Health Group had a negative return on equity of 12.66% and a negative net margin of 17.64%. On average, analysts expect LifeStance Health Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

LifeStance Health Group Trading Up 1.0 %

LFST stock opened at $6.98 on Wednesday. The company has a market cap of $2.67 billion, a P/E ratio of -13.69 and a beta of 1.29. LifeStance Health Group has a twelve month low of $4.74 and a twelve month high of $9.59. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.20. The business has a fifty day moving average of $6.45 and a 200-day moving average of $6.54.

Insider Buying and Selling

In related news, insider Danish J. Qureshi sold 12,965 shares of LifeStance Health Group stock in a transaction on Monday, April 1st. The stock was sold at an average price of $5.93, for a total transaction of $76,882.45. Following the completion of the sale, the insider now directly owns 4,911,050 shares of the company’s stock, valued at $29,122,526.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other LifeStance Health Group news, insider Kevin Michael Mullins sold 44,540 shares of the business’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $6.33, for a total value of $281,938.20. Following the completion of the transaction, the insider now directly owns 4,745,352 shares of the company’s stock, valued at $30,038,078.16. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Danish J. Qureshi sold 12,965 shares of the business’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $5.93, for a total value of $76,882.45. Following the completion of the transaction, the insider now directly owns 4,911,050 shares of the company’s stock, valued at $29,122,526.50. The disclosure for this sale can be found here. Insiders sold a total of 245,463 shares of company stock valued at $1,786,868 over the last three months. Company insiders own 6.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on LFST. Barclays boosted their target price on LifeStance Health Group from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Thursday, February 29th. Jefferies Financial Group boosted their target price on LifeStance Health Group from $8.00 to $9.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th. The Goldman Sachs Group lifted their price objective on LifeStance Health Group from $8.00 to $9.00 and gave the stock a “neutral” rating in a research note on Monday, March 4th. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $10.00 price objective on shares of LifeStance Health Group in a research note on Monday, April 22nd. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $8.83.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.